There have been 50 recent insider transactions recorded for Satsuma Pharmaceuticals, Inc. (STSA), including 34 buys and 15 sells. Total insider buying was valued at $55.79M and total insider selling at $8.88M.
Notable insiders with recent activity include King Thomas Braxton, Kollins John A, Soloway Thomas P. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — STSA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2023-06-08 |
King Thomas Braxton |
Director |
Return of Shares |
12,765 |
$0.90 |
$11.49K |
- |
| 2023-06-08 |
Kollins John A |
President and CEO |
Return of Shares |
127,659 |
$0.90 |
$114.89K |
- |
| 2023-06-08 |
Soloway Thomas P |
Director |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Lukatch Heath |
Director |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Shah Rajeev M. |
10 Percent Owner |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Sandoval Elisabeth |
Director |
Return of Shares |
14,893 |
$4.56 |
$67.91K |
- |
| 2023-06-08 |
O'neil Thomas P. |
Chief Financial Officer |
Return of Shares |
76,595 |
$1.04 |
$79.66K |
- |
| 2023-06-08 |
Takanashi Ken |
10 Percent Owner |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
Informative Buy |
8,423,732 |
$0.91 |
$7.67M |
8,423,732 |
| 2023-06-08 |
Harsch Mutya |
Director |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-08 |
Riebe Michael T |
Director |
Return of Shares |
12,765 |
$0.90 |
$11.49K |
- |
| 2023-06-08 |
Ra Capital Management, L.p. |
Officer |
Return of Shares |
30,000 |
$3.46 |
$103.8K |
- |
| 2023-06-06 |
Kollins John A |
President and CEO |
Tender Offer (Sell) |
305,911 |
$0.91 |
$278.38K |
- |
| 2023-06-06 |
Shah Rajeev M. |
10 Percent Owner |
Tender Offer (Sell) |
5,914,252 |
$0.91 |
$5.38M |
- |
| 2023-06-06 |
O'neil Thomas P. |
Chief Financial Officer |
Tender Offer (Sell) |
13,877 |
$0.91 |
$12.63K |
- |
| 2023-06-06 |
Takanashi Ken |
10 Percent Owner |
Informative Buy |
22,053,581 |
$0.91 |
$20.07M |
24,847,694 |
| 2023-06-06 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
Informative Buy |
22,053,581 |
$0.91 |
$20.07M |
22,053,581 |
| 2022-11-21 |
Leonard Braden Michael |
Director |
Informative Buy |
150,000 |
$0.71 |
$106.74K |
150,000 |
| 2022-11-15 |
Leonard Braden Michael |
Director |
Informative Buy |
531,000 |
$0.63 |
$336.71K |
6,139,306 |
| 2022-11-14 |
Leonard Braden Michael |
Director |
Unknown |
- |
- |
- |
5,608,306 |
| 2022-11-14 |
Leonard Braden Michael |
Director |
Informative Buy |
5,608,306 |
$0.69 |
$3.87M |
5,608,306 |
| 2022-11-14 |
Commodore Capital Lp |
Director |
Informative Sell |
3,250,000 |
$0.71 |
$2.29M |
461,286 |
| 2022-06-03 |
Takanashi Ken |
Director |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
King Thomas Braxton |
Director |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Albrecht Detlef |
Chief Medical Officer |
RSU Award |
190,000 |
- |
- |
190,000 |
| 2022-06-03 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU Award |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Kollins John A |
President and CEO |
RSU Award |
505,000 |
$3.46 |
$1.75M |
505,000 |
| 2022-06-03 |
Soloway Thomas P |
Director |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Lukatch Heath |
Director |
RSU Award |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Shah Rajeev M. |
Director |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2022-06-03 |
Sandoval Elisabeth |
Director |
RSU Award |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
O'neil Thomas P. |
Chief Financial Officer |
RSU Award |
190,000 |
- |
- |
190,000 |
| 2022-06-03 |
Takanashi Ken |
Director |
RSU Award |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Harsch Mutya |
Director |
RSU Award |
30,000 |
$3.46 |
$103.8K |
30,000 |
| 2022-06-03 |
Riebe Michael T |
Director |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2021-11-24 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
2,922 |
$5.42 |
$15.84K |
3,711,286 |
| 2021-11-22 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
9,979 |
$5.49 |
$54.78K |
3,708,364 |
| 2021-11-19 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
3,225 |
$5.44 |
$17.54K |
3,698,385 |
| 2021-11-11 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
7,941 |
$6.05 |
$48.04K |
3,695,160 |
| 2021-11-10 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
9,622 |
$5.85 |
$56.29K |
3,687,219 |
| 2021-11-08 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
560 |
$5.99 |
$3.35K |
3,677,597 |
| 2021-11-05 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
7,800 |
$5.95 |
$46.41K |
3,677,037 |
| 2021-11-04 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
1,400 |
$5.88 |
$8.23K |
3,669,237 |
| 2021-11-02 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
8,880 |
$5.64 |
$50.08K |
3,667,837 |
| 2021-10-29 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
44,651 |
$5.71 |
$254.96K |
3,658,957 |
| 2021-10-28 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
15,082 |
$5.55 |
$83.71K |
3,614,306 |
| 2021-10-27 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
39,581 |
$5.45 |
$215.72K |
3,599,224 |
| 2021-10-22 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
27,629 |
$5.51 |
$152.24K |
3,559,643 |
| 2021-10-21 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
32,816 |
$5.40 |
$177.21K |
3,532,014 |
| 2021-10-20 |
Commodore Capital Lp |
10 Percent Owner |
Informative Buy |
40,663 |
$5.44 |
$221.21K |
3,499,198 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
